Retrospective Study
Copyright ©The Author(s) 2025.
World J Hepatol. Mar 27, 2025; 17(3): 104534
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.104534
Figure 2
Figure 2 Area under the receiver operating characteristic curves for fibrosis and activity assessment using noninvasive tests. A: Area under the receiver operating characteristic curves (AUROCs) of FibroTest, vibration-controlled transient elastography (VCTE), and fibrosis-4 index (FIB-4) for the detection of significant fibrosis (F2, F3, and F4); B: AUROCs of FibroTest, VCTE, and FIB-4 for the detection of advanced fibrosis (F3 and F4); C: AUROCs of FibroTest, VCTE, and FIB-4 for the detection of liver cirrhosis (F4); D: AUROCs of ActiTest and alanine aminotransferase in the detection of advanced activity (A2 and A3).